van der Westhuizen ET - Search Results

1

Relaxin family peptides and their receptors.

Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ. Bathgate RA, et al. Among authors: van der westhuizen et. Physiol Rev. 2013 Jan;93(1):405-80. doi: 10.1152/physrev.00001.2012. Physiol Rev. 2013. PMID: 23303914 Free article. Review.

2

Responses of GPCR135 to human gene 3 (H3) relaxin in CHO-K1 cells determined by microphysiometry.

Van der Westhuizen ET, Sexton PM, Bathgate RA, Summers RJ. Van der Westhuizen ET, et al. Ann N Y Acad Sci. 2005 May;1041:332-7. doi: 10.1196/annals.1282.053. Ann N Y Acad Sci. 2005. PMID: 15956730

3

Relaxin receptors--new drug targets for multiple disease states.

Van Der Westhuizen ET, Summers RJ, Halls ML, Bathgate RA, Sexton PM. Van Der Westhuizen ET, et al. Curr Drug Targets. 2007 Jan;8(1):91-104. doi: 10.2174/138945007779315650. Curr Drug Targets. 2007. PMID: 17266534 Review.

4

Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Halls ML, van der Westhuizen ET, Bathgate RA, Summers RJ. Halls ML, et al. Among authors: van der westhuizen et. Br J Pharmacol. 2007 Mar;150(6):677-91. doi: 10.1038/sj.bjp.0707140. Epub 2007 Feb 12. Br J Pharmacol. 2007. PMID: 17293890 Free PMC article. Review.

5

The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.

van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ. van der Westhuizen ET, et al. Mol Pharmacol. 2007 Jun;71(6):1618-29. doi: 10.1124/mol.106.032763. Epub 2007 Mar 9. Mol Pharmacol. 2007. PMID: 17351017

6

Relaxin family peptide receptors--from orphans to therapeutic targets.

van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ. van der Westhuizen ET, et al. Drug Discov Today. 2008 Aug;13(15-16):640-51. doi: 10.1016/j.drudis.2008.04.002. Epub 2008 Jun 6. Drug Discov Today. 2008. PMID: 18675759 Review.

7

Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.

Halls ML, van der Westhuizen ET, Wade JD, Evans BA, Bathgate RA, Summers RJ. Halls ML, et al. Among authors: van der westhuizen et. Mol Pharmacol. 2009 Feb;75(2):415-28. doi: 10.1124/mol.108.051227. Epub 2008 Nov 24. Mol Pharmacol. 2009. PMID: 19029286

8

Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3.

Summers RJ, Bathgate RA, Wade JD, van der Westhuizen ET, Halls ML. Summers RJ, et al. Among authors: van der westhuizen et. Ann N Y Acad Sci. 2009 Apr;1160:99-104. doi: 10.1111/j.1749-6632.2009.03828.x. Ann N Y Acad Sci. 2009. PMID: 19416167

9

Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3.

van der Westhuizen ET, Wade JD, Sexton PM, Summers RJ. van der Westhuizen ET, et al. Ann N Y Acad Sci. 2009 Apr;1160:105-7. doi: 10.1111/j.1749-6632.2008.03818.x. Ann N Y Acad Sci. 2009. PMID: 19416168

10

H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).

van der Westhuizen ET, Christopoulos A, Sexton PM, Wade JD, Summers RJ. van der Westhuizen ET, et al. Mol Pharmacol. 2010 May;77(5):759-72. doi: 10.1124/mol.109.061432. Epub 2010 Feb 16. Mol Pharmacol. 2010. PMID: 20159943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters